Use of convalescent plasma in hospitalized patients with COVID-19: case series

Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2020-08, Vol.136 (6), p.759-762
Hauptverfasser:	Hegerova, Livia, Gooley, Ted A., Sweerus, Kelly A., Maree, Cynthia, Bailey, Neil, Bailey, Megumi, Dunleavy, Vanessa, Patel, Krish, Alcorn, Kirsten, Haley, Rebecca, Johnsen, Jill M., Konkle, Barbara A., Lahti, Annamarie C., Alexander, Morgan L., Goldman, Jason D., Lipke, Anne, Lim, Sun-jung, Sullivan, Mark D., Pauk, John S., Pagel, John M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Betacoronavirus - isolation & purification Blood Component Transfusion - methods Coronavirus Infections - diagnosis Coronavirus Infections - therapy COVID-19 COVID-19 Serotherapy Female Humans Immunization, Passive - methods Letter to Blood Male Middle Aged Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - therapy SARS-CoV-2 Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.
ISSN:	0006-4971 1528-0020 1528-0020
DOI:	10.1182/blood.2020006964